Image Credit: STAT News

STAT+: Pfizer kills hemophilia gene therapy deal, imperiling Sangamo

Watchdoq December 30, 2024

Sangamo, a gene therapy pioneer, loses a financial lifeline as Pfizer drops a gene therapy program for hemophilia.